Success stories 08 dez 2023 “Our first choice was and will always be Switzerland" M&K Global AG is a Bern-based holding company focusing on strategies for drone service integration, real-world implementation and education. ...
News 24 mai 2023 Latest research shows 20% of European biotechs now headquartered in Switzerland Press release New research conducted by IQVIA and recently published in the 2023 Swiss Biotech Report shows that 20% of European biotech companies are now head...
Success stories 18 dez 2023 „DIE SCHWEIZ WAR IMMER UNSERE ERSTE WAHL UND WIRD ES AUCH BLEIBEN“ Die M&K Global AG ist eine Holdinggesellschaft mit Sitz in Bern, die sich auf Strategien für die Integration von Drohnendiensten sowie deren ...
人材 23 ago 2023 人材 ライフサイエンス業界で優秀な人材をお探しですか?スイスは優秀な人材の宝庫として有名です。ライフサイエンス企業がスイスの膨大な人材プールから受けるメリットをご紹介します。
Headquarters 15 jun 2023 Open Your HQ Are you a biopharmaceutical company seeking to access the European market? Switzerland could be the perfect location for your commercial headquar...
Spotlight 15 jun 2023 Access to Ecosystem Switzerland is a global leader in biotech, medtech and pharma. Find out what makes the Swiss life science industry unique and how your life scien...
Talent 29 jun 2023 Find Talent Are you looking for skilled personnel in the Life Science industry? Switzerland is famous for its highly qualified workforce. Find out how your L...
研究・開発 04 jul 2023 企業の研究開発マネージメントとスイス スイスでは産学が現実に即した協力体制を取っており、それが製品の市場化までの時間を早めるのに大いに貢献しています。応用科学に重点を置くスイスのユニークな特徴が、貴社にどのようにお役に立てるかをご覧ください。
总部 27 jun 2023 设立您的公司总部 您是一家寻求进入欧洲市场的生物制药公司吗?瑞士可能是设立商业总部或区域中心的理想地点,可帮助您的企业覆盖整个欧洲,以及欧洲、中东和非洲市场的运营。瑞士的吸引力包括地处欧洲中心的战略位置、商业友好型的营商环境、有竞争力的公司和个人税收制度以及多样化的人才市场。默克雪兰诺(Merck Sero...
Aktuell 02 jun 2023 Neuste Forschung zeigt, dass 20% der europäischen Biotechs ihren Hauptsitz in der Schweiz haben Press release Neue Untersuchungen von IQVIA, die kürzlich im Swiss Biotech Report 2023 veröffentlicht wurden, zeigen, dass mittlerweile 20% der europäischen Bi...
Success stories 25 mai 2023 Merck : “Switzerland offers attractive and stable conditions for international companies.“ Merck Science and technology leader Merck has been in Switzerland for almost a century. Today it has eight sites, including five manufacturing faciliti...
Success stories 25 mai 2023 CSL Behring: “The deciding factors were time to market and the proven track record of the Bern site.” CSL Behring For over a century, CSL Behring (CSLB) has kept its founding promise to help patients suffering from rare and serious diseases. It specializes in...
Innovation 11 jul 2023 Locate Investors Discover how you can benefit from Switzerland's strong investor base and several accelerator programs to support the launch and growth of your li...
Research and Development 11 jul 2023 Benefit from R&D Switzerland’s pragmatic collaboration between science and industry can help your company expedite the journey of your products to market. Learn h...
Success stories 09 jun 2022 La Svizzera offre condizioni interessanti e stabili per le aziende internazionali Merck Il leader scientifico e tecnologico Merck è presente in Svizzera da quasi un secolo. Oggi ha otto sedi, tra cui cinque impianti di produzione, e ...
Aktuell 04 abr 2023 Standortpromotion 2022: Positive Ansiedlungszahlen trotz herausforderndem Marktumfeld Die Statistik der Standortpromotion von Bund, Kantonen und Regionen schliesst 2022 insgesamt positiv ab. Total konnten 265 Firmen angesiedelt wer...
Report 21 jul 2021 Key Swiss Circular Economy Features In our current linear economic model the principle of "take-make-waste" dominates. This economic model leads to resource scarcity, waste and ulti...
Commercial HQ in Switzerl... 09 mai 2023 Commercial HQ in Switzerland Setting up Your Commercial HQ in Switzerland: The Key to European Market Success: Are you a pharmaceutical company seeking to access the European...